- Home
- ICHR vs ELVN Comparison
ICHR vs ELVN Comparison
Compare ICHR & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICHR
- ELVN
- Stock Information
- Founded
- ICHR 1999
- ELVN 2016
- Country
- ICHR United States
- ELVN United States
- Employees
- ICHR N/A
- ELVN N/A
- Industry
- ICHR Semiconductors
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- ICHR Technology
- ELVN Health Care
- Exchange
- ICHR Nasdaq
- ELVN Nasdaq
- Market Cap
- ICHR 727.6M
- ELVN 927.8M
- IPO Year
- ICHR 2016
- ELVN 2020
- Fundamental
- Price
- ICHR $20.04
- ELVN $21.36
- Analyst Decision
- ICHR Strong Buy
- ELVN Strong Buy
- Analyst Count
- ICHR 6
- ELVN 5
- Target Price
- ICHR $35.20
- ELVN $39.60
- AVG Volume (30 Days)
- ICHR 458.8K
- ELVN 716.7K
- Earning Date
- ICHR 08-05-2025
- ELVN 08-12-2025
- Dividend Yield
- ICHR N/A
- ELVN N/A
- EPS Growth
- ICHR N/A
- ELVN N/A
- EPS
- ICHR N/A
- ELVN N/A
- Revenue
- ICHR $892,122,000.00
- ELVN N/A
- Revenue This Year
- ICHR $14.18
- ELVN N/A
- Revenue Next Year
- ICHR $6.66
- ELVN N/A
- P/E Ratio
- ICHR N/A
- ELVN N/A
- Revenue Growth
- ICHR 13.41
- ELVN N/A
- 52 Week Low
- ICHR $15.33
- ELVN $13.30
- 52 Week High
- ICHR $42.70
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- ICHR 59.50
- ELVN 55.84
- Support Level
- ICHR $18.68
- ELVN $20.22
- Resistance Level
- ICHR $17.86
- ELVN $24.11
- Average True Range (ATR)
- ICHR 0.81
- ELVN 1.69
- MACD
- ICHR 0.24
- ELVN -0.02
- Stochastic Oscillator
- ICHR 90.33
- ELVN 53.58
About ICHR Ichor Holdings
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.